| Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer M Peifer, L Fernández-Cuesta, ML Sos, J George, D Seidel, LH Kasper, ... Nature genetics 44 (10), 1104-1110, 2012 | 1529 | 2012 |
| Telomerase activation by genomic rearrangements in high-risk neuroblastoma M Peifer, F Hertwig, F Roels, D Dreidax, M Gartlgruber, R Menon, ... Nature 526 (7575), 700-704, 2015 | 642 | 2015 |
| A mechanistic classification of clinical phenotypes in neuroblastoma S Ackermann, M Cartolano, B Hero, A Welte, Y Kahlert, A Roderwieser, ... Science 362 (6419), 1165-1170, 2018 | 321 | 2018 |
| Emergence of New ALK Mutations at Relapse of Neuroblastoma G Schleiermacher, N Javanmardi, V Bernard, Q Leroy, J Cappo, ... Journal of Clinical Oncology 32 (25), 2727-2734, 2014 | 212 | 2014 |
| Targeted expression of mutated ALK induces neuroblastoma in transgenic mice LC Heukamp, T Thor, A Schramm, K De Preter, C Kumps, B De Wilde, ... Science translational medicine 4 (141), 141ra91-141ra91, 2012 | 207 | 2012 |
| Shallow whole genome sequencing on circulating cell-free DNA allows reliable noninvasive copy-number profiling in neuroblastoma patients N Van Roy, M Van Der Linden, B Menten, A Dheedene, C Vandeputte, ... Clinical Cancer Research 23 (20), 6305-6314, 2017 | 128 | 2017 |
| Accelerating drug development for neuroblastoma: summary of the second neuroblastoma drug development strategy forum from innovative therapies for children with cancer and … L Moreno, G Barone, SG DuBois, J Molenaar, M Fischer, J Schulte, ... European Journal of Cancer 136, 52-68, 2020 | 66 | 2020 |
| The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review R Van Paemel, R Vlug, K De Preter, N Van Roy, F Speleman, L Willems, ... European journal of pediatrics 179, 191-202, 2020 | 62 | 2020 |
| Practical tools to implement massive parallel pyrosequencing of PCR products in next generation molecular diagnostics K De Leeneer, J De Schrijver, L Clement, M Baetens, S Lefever, ... PLoS One 6 (9), e25531, 2011 | 53 | 2011 |
| Massively parallel sequencing for early molecular diagnosis in Leber congenital amaurosis F Coppieters, B De Wilde, S Lefever, E De Meester, N De Rocker, ... Genetics in medicine 14 (6), 576-585, 2012 | 51 | 2012 |
| Minimally invasive classification of paediatric solid tumours using reduced representation bisulphite sequencing of cell-free DNA: a proof-of-principle study R Van Paemel, A De Koker, C Vandeputte, L van Zogchel, T Lammens, ... Epigenetics 16 (2), 196-208, 2021 | 43 | 2021 |
| Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma A Decock, M Ongenaert, R Cannoodt, K Verniers, B De Wilde, G Laureys, ... Oncotarget 7 (2), 1960, 2015 | 33 | 2015 |
| ALK positively regulates MYCN activity through repression of HBP1 expression S Claeys, G Denecker, K Durinck, B Decaesteker, LM Mus, S Loontiens, ... Oncogene 38 (15), 2690-2705, 2019 | 32 | 2019 |
| Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait A Decock, M Ongenaert, B De Wilde, B Brichard, R Noguera, F Speleman, ... Epigenetics 11 (10), 761-771, 2016 | 30 | 2016 |
| Genome-wide study of the effect of blood collection tubes on the cell-free DNA methylome R Van Paemel, A De Koker, C Caggiano, A Morlion, P Mestdagh, ... Epigenetics 16 (7), 797-807, 2021 | 29 | 2021 |
| RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition C Nunes, L Depestel, L Mus, KM Keller, L Delhaye, A Louwagie, M Rishfi, ... Science advances 8 (28), eabn1382, 2022 | 28 | 2022 |
| The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness LM Mus, I Lambertz, S Claeys, C Kumps, W Van Loocke, C Van Neste, ... Scientific Reports 10 (1), 218, 2020 | 28 | 2020 |
| Target enrichment using parallel nanoliter quantitative PCR amplification B De Wilde, S Lefever, W Dong, J Dunne, S Husain, S Derveaux, ... BMC genomics 15, 1-14, 2014 | 27 | 2014 |
| Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: a report from the Innovative Therapies for Children with Cancer (ITCC) consortium A Rubio-San-Simón, N André, MG Cefalo, I Aerts, A Castañeda, ... European Journal of Cancer 141, 82-91, 2020 | 25 | 2020 |
| Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM H Peterziel, N Jamaladdin, D ElHarouni, XF Gerloff, S Herter, P Fiesel, ... NPJ precision oncology 6 (1), 94, 2022 | 22 | 2022 |
Katleen De Preterfull research professor, Ghent UniversityVerified email at ugent.be
